【調査レポート】世界の骨形成不全症治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Osteogenesis Imperfecta Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の骨形成不全症治療市場規模・現状・予測（2021年-2027年） / Global Osteogenesis Imperfecta Treatment Market Size, Status and Forecast 2021-2027 / QYR2104Z4347資料のイメージです。

• レポートコード：QYR2104Z4347
• 出版社/出版日：QYResearch / 2021年4月15日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、骨形成不全症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（KAL-436、BPS-804、ALLOB、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・骨形成不全症治療の市場動向
・企業の競争状況、市場シェア
・骨形成不全症治療の種類別市場規模（KAL-436、BPS-804、ALLOB、その他）
・骨形成不全症治療の用途別市場規模（病院、診療所、その他）
・骨形成不全症治療の北米市場規模2016-2027（アメリカ、カナダ）
・骨形成不全症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・骨形成不全症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・骨形成不全症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・骨形成不全症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Amgen Inc、Bone Therapeutics SA、Genzyme Corp、Mereo Biopharma Group Plc）
・結論

Market Analysis and Insights: Global Osteogenesis Imperfecta Treatment Market
The global Osteogenesis Imperfecta Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteogenesis Imperfecta Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteogenesis Imperfecta Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteogenesis Imperfecta Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteogenesis Imperfecta Treatment market.

Global Osteogenesis Imperfecta Treatment Scope and Market Size
Osteogenesis Imperfecta Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Osteogenesis Imperfecta Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
KAL-436
BPS-804
ALLOB
Others

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen Inc
Bone Therapeutics SA
Genzyme Corp

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteogenesis Imperfecta Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 KAL-436
1.2.3 BPS-804
1.2.4 ALLOB
1.2.5 Others
1.3 Market by Application
1.3.1 Global Osteogenesis Imperfecta Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Osteogenesis Imperfecta Treatment Market Perspective (2016-2027)
2.2 Osteogenesis Imperfecta Treatment Growth Trends by Regions
2.2.1 Osteogenesis Imperfecta Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Osteogenesis Imperfecta Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Osteogenesis Imperfecta Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Osteogenesis Imperfecta Treatment Industry Dynamic
2.3.1 Osteogenesis Imperfecta Treatment Market Trends
2.3.2 Osteogenesis Imperfecta Treatment Market Drivers
2.3.3 Osteogenesis Imperfecta Treatment Market Challenges
2.3.4 Osteogenesis Imperfecta Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Osteogenesis Imperfecta Treatment Players by Revenue
3.1.1 Global Top Osteogenesis Imperfecta Treatment Players by Revenue (2016-2021)
3.1.2 Global Osteogenesis Imperfecta Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Osteogenesis Imperfecta Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Osteogenesis Imperfecta Treatment Revenue
3.4 Global Osteogenesis Imperfecta Treatment Market Concentration Ratio
3.4.1 Global Osteogenesis Imperfecta Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteogenesis Imperfecta Treatment Revenue in 2020
3.5 Osteogenesis Imperfecta Treatment Key Players Head office and Area Served
3.6 Key Players Osteogenesis Imperfecta Treatment Product Solution and Service
3.7 Date of Enter into Osteogenesis Imperfecta Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Osteogenesis Imperfecta Treatment Breakdown Data by Type
4.1 Global Osteogenesis Imperfecta Treatment Historic Market Size by Type (2016-2021)
4.2 Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Type (2022-2027)

5 Osteogenesis Imperfecta Treatment Breakdown Data by Application
5.1 Global Osteogenesis Imperfecta Treatment Historic Market Size by Application (2016-2021)
5.2 Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Osteogenesis Imperfecta Treatment Market Size (2016-2027)
6.2 North America Osteogenesis Imperfecta Treatment Market Size by Type
6.2.1 North America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021)
6.2.2 North America Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027)
6.2.3 North America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2027)
6.3 North America Osteogenesis Imperfecta Treatment Market Size by Application
6.3.1 North America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021)
6.3.2 North America Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027)
6.3.3 North America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2027)
6.4 North America Osteogenesis Imperfecta Treatment Market Size by Country
6.4.1 North America Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021)
6.4.2 North America Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Osteogenesis Imperfecta Treatment Market Size (2016-2027)
7.2 Europe Osteogenesis Imperfecta Treatment Market Size by Type
7.2.1 Europe Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021)
7.2.2 Europe Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027)
7.2.3 Europe Osteogenesis Imperfecta Treatment Market Size by Type (2016-2027)
7.3 Europe Osteogenesis Imperfecta Treatment Market Size by Application
7.3.1 Europe Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021)
7.3.2 Europe Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027)
7.3.3 Europe Osteogenesis Imperfecta Treatment Market Size by Application (2016-2027)
7.4 Europe Osteogenesis Imperfecta Treatment Market Size by Country
7.4.1 Europe Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021)
7.4.2 Europe Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size (2016-2027)
8.2 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type
8.2.1 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application
8.3.1 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Region
8.4.1 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Osteogenesis Imperfecta Treatment Market Size (2016-2027)
9.2 Latin America Osteogenesis Imperfecta Treatment Market Size by Type
9.2.1 Latin America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2027)
9.3 Latin America Osteogenesis Imperfecta Treatment Market Size by Application
9.3.1 Latin America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2027)
9.4 Latin America Osteogenesis Imperfecta Treatment Market Size by Country
9.4.1 Latin America Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size (2016-2027)
10.2 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type
10.2.1 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application
10.3.1 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Country
10.4.1 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen Inc
11.1.1 Amgen Inc Company Details
11.1.2 Amgen Inc Business Overview
11.1.3 Amgen Inc Osteogenesis Imperfecta Treatment Introduction
11.1.4 Amgen Inc Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021)
11.1.5 Amgen Inc Recent Development
11.2 Bone Therapeutics SA
11.2.1 Bone Therapeutics SA Company Details
11.2.2 Bone Therapeutics SA Business Overview
11.2.3 Bone Therapeutics SA Osteogenesis Imperfecta Treatment Introduction
11.2.4 Bone Therapeutics SA Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021)
11.2.5 Bone Therapeutics SA Recent Development
11.3 Genzyme Corp
11.3.1 Genzyme Corp Company Details
11.3.2 Genzyme Corp Business Overview
11.3.3 Genzyme Corp Osteogenesis Imperfecta Treatment Introduction
11.3.4 Genzyme Corp Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021)
11.3.5 Genzyme Corp Recent Development
11.4 Mereo Biopharma Group Plc
11.4.1 Mereo Biopharma Group Plc Company Details
11.4.2 Mereo Biopharma Group Plc Business Overview
11.4.3 Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Introduction
11.4.4 Mereo Biopharma Group Plc Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021)
11.4.5 Mereo Biopharma Group Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Osteogenesis Imperfecta Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of KAL-436
Table 3. Key Players of BPS-804
Table 4. Key Players of ALLOB
Table 5. Key Players of Others
Table 6. Global Osteogenesis Imperfecta Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Osteogenesis Imperfecta Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Osteogenesis Imperfecta Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2016-2021)
Table 10. Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2022-2027)
Table 12. Osteogenesis Imperfecta Treatment Market Trends
Table 13. Osteogenesis Imperfecta Treatment Market Drivers
Table 14. Osteogenesis Imperfecta Treatment Market Challenges
Table 15. Osteogenesis Imperfecta Treatment Market Restraints
Table 16. Global Osteogenesis Imperfecta Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Osteogenesis Imperfecta Treatment Market Share by Players (2016-2021)
Table 18. Global Top Osteogenesis Imperfecta Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2020)
Table 19. Ranking of Global Top Osteogenesis Imperfecta Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Osteogenesis Imperfecta Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Osteogenesis Imperfecta Treatment Product Solution and Service
Table 23. Date of Enter into Osteogenesis Imperfecta Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Osteogenesis Imperfecta Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Osteogenesis Imperfecta Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Amgen Inc Company Details
Table 64. Amgen Inc Business Overview
Table 65. Amgen Inc Osteogenesis Imperfecta Treatment Product
Table 66. Amgen Inc Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021) & (US$ Million)
Table 67. Amgen Inc Recent Development
Table 68. Bone Therapeutics SA Company Details
Table 69. Bone Therapeutics SA Business Overview
Table 70. Bone Therapeutics SA Osteogenesis Imperfecta Treatment Product
Table 71. Bone Therapeutics SA Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021) & (US$ Million)
Table 72. Bone Therapeutics SA Recent Development
Table 73. Genzyme Corp Company Details
Table 74. Genzyme Corp Business Overview
Table 75. Genzyme Corp Osteogenesis Imperfecta Treatment Product
Table 76. Genzyme Corp Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021) & (US$ Million)
Table 77. Genzyme Corp Recent Development
Table 78. Mereo Biopharma Group Plc Company Details
Table 79. Mereo Biopharma Group Plc Business Overview
Table 80. Mereo Biopharma Group Plc Osteogenesis Imperfecta Treatment Product
Table 81. Mereo Biopharma Group Plc Revenue in Osteogenesis Imperfecta Treatment Business (2016-2021) & (US$ Million)
Table 82. Mereo Biopharma Group Plc Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteogenesis Imperfecta Treatment Market Share by Type: 2020 VS 2027
Figure 2. KAL-436 Features
Figure 3. BPS-804 Features
Figure 4. ALLOB Features
Figure 5. Others Features
Figure 6. Global Osteogenesis Imperfecta Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Osteogenesis Imperfecta Treatment Report Years Considered
Figure 11. Global Osteogenesis Imperfecta Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Osteogenesis Imperfecta Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Osteogenesis Imperfecta Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Osteogenesis Imperfecta Treatment Market Share by Regions (2022-2027)
Figure 15. Global Osteogenesis Imperfecta Treatment Market Share by Players in 2020
Figure 16. Global Top Osteogenesis Imperfecta Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteogenesis Imperfecta Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Osteogenesis Imperfecta Treatment Revenue in 2020
Figure 18. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Osteogenesis Imperfecta Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Osteogenesis Imperfecta Treatment Market Share by Type (2016-2027)
Figure 22. North America Osteogenesis Imperfecta Treatment Market Share by Application (2016-2027)
Figure 23. North America Osteogenesis Imperfecta Treatment Market Share by Country (2016-2027)
Figure 24. United States Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Osteogenesis Imperfecta Treatment Market Share by Type (2016-2027)
Figure 28. Europe Osteogenesis Imperfecta Treatment Market Share by Application (2016-2027)
Figure 29. Europe Osteogenesis Imperfecta Treatment Market Share by Country (2016-2027)
Figure 30. Germany Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Osteogenesis Imperfecta Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Osteogenesis Imperfecta Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Osteogenesis Imperfecta Treatment Market Share by Region (2016-2027)
Figure 40. China Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Osteogenesis Imperfecta Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Osteogenesis Imperfecta Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Osteogenesis Imperfecta Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Osteogenesis Imperfecta Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Osteogenesis Imperfecta Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Osteogenesis Imperfecta Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Osteogenesis Imperfecta Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Amgen Inc Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2016-2021)
Figure 60. Bone Therapeutics SA Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2016-2021)
Figure 61. Genzyme Corp Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2016-2021)
Figure 62. Mereo Biopharma Group Plc Revenue Growth Rate in Osteogenesis Imperfecta Treatment Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の前立腺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Prostate Cancer Treatment Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4831 2021年4月15日 93Pages
QYResearch社発行の本調査資料では、前立腺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ザイティガ、ゴナックス、リュープリン、ゾラデックス、デカペプチル、エリガード、Vantas、カソデックス、その他）、用途別市場規模（病院...

世界の本態性血小板血症骨髄線維症治療市場規模・現状・予測（2021年-2027年）

Global Thrombocythaemia Myelofibrosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5643 2021年4月15日 96Pages
QYResearch社発行の本調査資料では、本態性血小板血症骨髄線維症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラシノスタット、ルミネスピブ、シムツズマブ、INCB-39110、その他）、用途別市場規模（クリニック、病院、その他）、...

世界の顔面紅斑治療市場規模・現状・予測（2021年-2027年）

Global Facial Erythema Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2302 2021年4月15日 97Pages
QYResearch社発行の本調査資料では、顔面紅斑治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（Rx、OTC）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド...

世界の光沢苔癬治療市場規模・現状・予測（2021年-2027年）

Global Lichen Nitidus Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3411 2021年4月15日 92Pages
QYResearch社発行の本調査資料では、光沢苔癬治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口）、用途別市場規模（病院、皮膚科クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、イ...

世界の筋萎縮性側索硬化症（ALS）治療市場規模・現状・予測（2021年-2027年）

Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0300 2021年4月10日 92Pages
QYResearch社発行の本調査資料では、筋萎縮性側索硬化症（ALS）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（リルゾール、エダラボン（ラディカバ）、その他）、用途別市場規模（病院、ドラッグストア、その他）、主要地域別市場規模（北米...